Post by Boston Scientific on X
Boston Scientific@bostonsci
XWe have officially closed the acquisition of @BoltIVL. We look forward to advancing the intravascular lithotripsy (IVL) therapy developed by Bolt which will complement our cardiovascular portfolio by expanding treatment options for coronary and peripheral disease. $BSX
35 likes19 repliesPosted Apr 2, 2025